A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis-Reference-Cited by-同舟云学术

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

Published:2007 Issue:9 Volume:56 Page:3096-3106
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Ruperto Nicolino,Lovell Daniel J.,Cuttica Ruben,Wilkinson Nick,Woo Patricia,Espada Graciela,Wouters Carine,Silverman Earl D.,Balogh Zsolt,Henrickson Michael,Apaz Maria-Teresa,Baildam Eileen,Fasth Anders,Gerloni Valeria,Lahdenne Pekka,Prieur Anne-Marie,Ravelli Angelo,Saurenmann Rotraud K.,Gamir Maria Luz,Wulffraat Nico,Marodi Laszlo,Petty Ross E.,Joos Rik,Zulian Francesco,McCurdy Deborah,Myones Barry L.,Nagy Kalman,Reuman Peter,Szer Ilona,Travers Suzanne,Beutler Anna,Keenan Greg,Clark Jason,Visvanathan Sudha,Fasanmade Adedigbo,Raychaudhuri Aparna,Mendelsohn Alan,Martini Alberto,Giannini Edward H., ,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference30 articles.

1. Juvenile rheumatoid arthritis in rochester, minnesota 1960–1993. Is the epidemiology changing?

2. Long-term outcome in patients with juvenile idiopathic arthritis

3. Methotrexate in Resistant Juvenile Rheumatoid Arthritis

Cited by 345 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can trial designs better serve the needs of children and young people with juvenile idiopathic arthritis?;The Lancet Rheumatology;2024-09

2. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study;Annals of the Rheumatic Diseases;2024-06-07

3. Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review;Modern Rheumatology;2024-05-25

4. Quantifying proportion of treatment effect by surrogate endpoint under heterogeneity;Statistical Methods in Medical Research;2024-05-08

5. Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis;Pharmacoepidemiology and Drug Safety;2024-04-29